- Home
- DY vs ROIV Comparison
DY vs ROIV Comparison
Compare DY & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DY
- ROIV
- Stock Information
- Founded
- DY 1969
- ROIV 2014
- Country
- DY United States
- ROIV United Kingdom
- Employees
- DY N/A
- ROIV N/A
- Industry
- DY Water Sewer Pipeline Comm & Power Line Construction
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- DY Industrials
- ROIV Health Care
- Exchange
- DY Nasdaq
- ROIV Nasdaq
- Market Cap
- DY 7.3B
- ROIV 8.6B
- IPO Year
- DY N/A
- ROIV N/A
- Fundamental
- Price
- DY $283.97
- ROIV $18.82
- Analyst Decision
- DY Strong Buy
- ROIV Strong Buy
- Analyst Count
- DY 11
- ROIV 8
- Target Price
- DY $282.45
- ROIV $21.06
- AVG Volume (30 Days)
- DY 306.3K
- ROIV 7.6M
- Earning Date
- DY 11-19-2025
- ROIV 11-10-2025
- Dividend Yield
- DY N/A
- ROIV N/A
- EPS Growth
- DY 10.50
- ROIV N/A
- EPS
- DY 8.89
- ROIV N/A
- Revenue
- DY $4,993,083,000.00
- ROIV $23,233,000.00
- Revenue This Year
- DY $17.12
- ROIV N/A
- Revenue Next Year
- DY $8.46
- ROIV $320.50
- P/E Ratio
- DY $32.44
- ROIV N/A
- Revenue Growth
- DY 12.61
- ROIV N/A
- 52 Week Low
- DY $131.37
- ROIV $8.73
- 52 Week High
- DY $301.88
- ROIV $18.96
- Technical
- Relative Strength Index (RSI)
- DY 49.01
- ROIV 81.18
- Support Level
- DY $277.40
- ROIV $17.89
- Resistance Level
- DY $291.61
- ROIV $18.96
- Average True Range (ATR)
- DY 9.53
- ROIV 0.50
- MACD
- DY -1.78
- ROIV 0.06
- Stochastic Oscillator
- DY 39.42
- ROIV 95.45
About DY Dycom Industries Inc.
Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. Its operating companies supply telecommunications providers with a comprehensive portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services and provide underground facility locating services for various utilities, including telecommunications providers, and others. It also provides a range of construction, maintenance, and installation services, including the placement and splicing of fiber, copper, and coaxial cables. It provides services throughout the United States.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.